Home

Sergio Traversa, CEO: Relmada Therapeutics RLMD Buy · Filed 25/12/16

Trade details

Type
Insider buy
Amount
$113,300
Shares · price
27,500 sh · $4.12 a share
Held after
1,300,000 sh
Trade date
25/12/15
Filed
25/12/16
Days to filing
1 days

First buy since 2023

Insiders buying this week
2 insiders
Holding change
+2.2%

Relmada Therapeutics trades, last 26 weeks

What else happened in Relmada Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/15~01/14

Sergio Traversa's recent trades

  • Sergio Traversa

    BuyRelmada Therapeutics

    $599.5K

    Filed 25/11/06

  • Sergio Traversa

    BuyRelmada Therapeutics

    $86.7K

    Filed 25/08/28

  • Sergio Traversa

    BuyRelmada Therapeutics

    $49.9K

    Filed 25/08/28

  • Sergio Traversa

    BuyRelmada Therapeutics

    $41.4K

    Filed 25/08/28

  • Sergio Traversa

    BuyRelmada Therapeutics

    $82.7K

    Filed 25/05/20